Foresite Capital Opportunity Management V, LLC Theseus Pharmaceuticals, Inc. Call Options Transaction History

Foresite Capital Opportunity Management V, LLC

  • $33.3 Million
  • Q3 2022

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding THRX

# of Institutions
3
Shares Held
1.06M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Foresite Capital Opportunity Management V, LLC Portfolio

Follow Foresite Capital Opportunity Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email